Registration Dossier

Identification

Chemical structure
Display Name:
4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide
EC Number:
448-010-8
EC Name:
4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide
Molecular formula:
C16H14N2O3S
IUPAC Name:
4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonamide

Total tonnage band

Total range:
Tonnage Data Confidential

REACH

Registered as:
INTERMEDIATE
Submitted:
Joint Submission

Publication dates

First published:
17-Aug-2016
Last modified:
23-Sep-2019

Chemical safety assessment

Performed for this substance:
NO

Compositions open all close all

Type:
legal entity composition of the substance
State Form:
solid: particulate/powder


Constituent 1
Chemical structure
Reference substance name:
4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide
EC Number:
448-010-8
EC Name:
4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide
Molecular formula:
C16H14N2O3S
IUPAC Name:
4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonamide
Type:
legal entity composition of the substance
State Form:
solid: particulate/powder


Registrants /Suppliers of the substance open all close all

Latest dossier received
Registrant / Supplier details 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
o Pfizer Ireland Pharmaceuticals n/a n/a Ringaskiddy Cork Ireland X
Piramal Healthcare UK Ltd Whalton Road NE61 3YA Morpeth Northumberland United Kingdom X

Administrative data open all close all

  • 01-0000018924-62-0003
  • 01-0000018924-62-0005

Contact Persons responsible for the SDS